Peptide Research March 19, 2026

Psoriasis Research Overview

Evolving from the study of traditional TNF and IL-17/23 cytokine pathways toward an integrated, systems-level understanding of how emerging peptides like BPC-157 and GHK-Cu modulate cellular communication.

Contents

Introduction Conventional Research Pathways Emerging Peptide Research Research Use Notice

Psoriasis is studied in research environments as a model of inflammatory skin activity involving immune signaling, cytokines, and cellular turnover.

Conventional Research Pathways

Research focuses on TNF signaling and interleukin pathways such as IL-17 and IL-23, which are associated with inflammatory responses.

TNF
IL-17/23
Peptides
TNF IL-17/23 Peptides

Emerging Peptide Research

Peptides such as BPC-157, TB-500, GHK-Cu, and LL-37 are being explored in laboratory settings for signaling and cellular communication roles.

BPC-157

  • Tissue repair and regeneration
  • Angiogenesis support
  • Cellular signaling modulation

TB-500

  • Actin regulation
  • Wound healing acceleration
  • Muscle recovery facilitation

GHK-Cu

  • Collagen synthesis
  • Skin regeneration
  • Anti-inflammatory signaling

LL-37

  • Antimicrobial activity
  • Immune modulation
  • Cellular signaling regulation
Note: These peptides are in preclinical or early clinical studies. Human effects are still under investigation. For a broader overview of metabolic peptides currently under investigation, see Metabolic Peptides Being Studied in 2026.
Research Use Notice

All materials referenced are intended strictly for laboratory research and educational discussion purposes only. Products referenced are not intended for human or veterinary use. Information provided is not intended to diagnose, treat, cure, or prevent any disease.

Not for Human Consumption Laboratory Research Only Not for Medical Use